Gianfranco Maffei
Overview
Explore the profile of Gianfranco Maffei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Indrio F, Masciari E, Marchese F, Rinaldi M, Maffei G, Gangai I, et al.
Heliyon
. 2025 Jan;
11(1):e41516.
PMID: 39834435
Background: Functional Gastrointestinal Disorders (FGIDs) can pose a great burden on affected children, their families, and the healthcare system. Due to the lack of knowledge about the precise pathophysiology of...
2.
Dani C, Poggi C, Agosti M, Bellettato M, Betta P, Biban P, et al.
Ital J Pediatr
. 2025 Jan;
51(1):1.
PMID: 39757182
Background: The issue of retreatment with surfactant of infants with respiratory distress syndrome (RDS) has been poorly investigated. Our aim was to identify possible clinical predictors of the need for...
3.
Gallini F, De Rose D, Iuliano R, Romeo D, Tana M, Paladini A, et al.
JAMA Netw Open
. 2024 Sep;
7(9):e2435347.
PMID: 39320892
Importance: A multicenter randomized clinical trial (RCT) showed a lung recruitment maneuver using high-frequency oscillatory ventilation just before surfactant administration (ie, intubate-recruit-surfactant-extubate [IN-REC-SUR-E]) improved the efficacy of treatment compared with...
4.
Dimopoulou V, Klingenberg C, Naver L, Nordberg V, Berardi A, El Helou S, et al.
Pediatr Res
. 2024 Sep;
PMID: 39289592
Background: Early-life antibiotic exposure is disproportionately high compared to the burden of culture-proven early-onset sepsis (CP-EOS). We assessed the contribution of culture-negative cases to the overall antibiotic exposure in the...
5.
Villani G, Zaza P, Lamparelli R, Maffei G
Sci Rep
. 2024 Jun;
14(1):14043.
PMID: 38890505
In humans, nephrogenesis is completed by 32-36 weeks gestation, with a highly variable total number of nephrons, ranging from 200,000 to over 2 million. Premature birth disrupts the development and...
6.
Fortunato F, Campanozzi A, Maffei G, Arena F, Carri V, Rollo T, et al.
Ital J Pediatr
. 2024 Mar;
50(1):45.
PMID: 38454523
Background: Respiratory syncytial virus (RSV), a single-stranded RNA virus, is a leading cause of hospitalization in infants, especially ≤ 2 months of life. In the light new immunization strategies adoption,...
7.
Dani C, Napolitano M, Barone C, Manna A, Nigro G, Scarpelli G, et al.
Pediatr Pulmonol
. 2024 Mar;
59(4):1006-1014.
PMID: 38441525
Introduction: Approximately half of very preterm infants with respiratory distress syndrome (RDS) fail treatment with nasal continuous positive airway pressure (NCPAP) and need mechanical ventilation (MV). Objectives: Our aim with...
8.
Pugni L, Crippa B, Raimondi F, Vento G, Mangili G, Coscia A, et al.
Int J Infect Dis
. 2023 Dec;
140:17-24.
PMID: 38157929
Objectives: To describe how SARS-CoV-2 infection at the time of delivery affected maternal and neonatal outcomes across four major waves of the COVID-19 pandemic in Italy. Methods: This is a...
9.
Baldassarre M, Loconsole D, Centrone F, Caselli D, Martire B, Quartulli L, et al.
Ital J Pediatr
. 2023 Jun;
49(1):66.
PMID: 37280662
Background: Bronchiolitis is a major cause of hospitalization in infants, particularly in the first six months of life, with approximately 60-80% of admissions due to respiratory syncytial virus (RSV) infection....
10.
Stocker M, Klingenberg C, Naver L, Nordberg V, Berardi A, El Helou S, et al.
Nat Commun
. 2023 Apr;
14(1):2423.
PMID: 37105958
Antibiotic exposure at the beginning of life can lead to increased antimicrobial resistance and perturbations of the developing microbiome. Early-life microbiome disruption increases the risks of developing chronic diseases later...